These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6788934)

  • 21. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
    Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
    Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

  • 24. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
    Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V
    Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):672-8. PubMed ID: 6641933
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds.
    Mascarello A; Frederico MJ; Castro AJ; Mendes CP; Dutra MF; Woehl VM; Yunes RA; Mena Barreto Silva FR; Nunes RJ
    Eur J Med Chem; 2014 Oct; 86():491-501. PubMed ID: 25203779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and blood glucose lowering activity of some novel benzenesulfonylthiourea derivatives substituted with 4-aryl-1-oxophthalazin-2(1H)yl-ones.
    Yaseen S; Bashir R; Ovais S; Rathore P; Samim M; Javed K
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):362-6. PubMed ID: 23578313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pyrazolic derivatives with hypoglycemic activity].
    Lotti B; Vezzosi O
    Farmaco Sci; 1972 Apr; 27(4):313-6. PubMed ID: 5024000
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents.
    Zhang HB; Zhang YA; Wu GZ; Zhou JP; Huang WL; Hu XW
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1740-4. PubMed ID: 19216076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of some acylamide derivatives as potential hypoglycemic agents.
    Srivastava V; Suresh AJ; Pandeya SN; Pandey A
    Boll Chim Farm; 1996; 135(7):452-7. PubMed ID: 9035557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes.
    Koyuturk M; Ozsoy-Sacan O; Bolkent S; Yanardag R
    Indian J Exp Biol; 2005 Mar; 43(3):268-71. PubMed ID: 15816415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adamantane-Isothiourea Hybrid Derivatives: Synthesis, Characterization, In Vitro Antimicrobial, and In Vivo Hypoglycemic Activities.
    Al-Wahaibi LH; Hassan HM; Abo-Kamar AM; Ghabbour HA; El-Emam AA
    Molecules; 2017 Apr; 22(5):. PubMed ID: 28468231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and hypoglycemic activity of some new theophylline derivatives.
    Alafeefy AM; Alqasoumi SI; Abdel Hamid SG; El-Tahir KE; Mohamed M; Zain ME; Awaad AS
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):443-8. PubMed ID: 23701264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antidiabetic activity of 3,6,7-trisubstituted-2-(1H-imidazol-2-ylsulfanyl)quinoxalines and quinoxalin-2-yl isothioureas.
    Bahekar RH; Jain MR; Gupta AA; Goel A; Jadav PA; Patel DN; Prajapati VM; Patel PR
    Arch Pharm (Weinheim); 2007 Jul; 340(7):359-66. PubMed ID: 17567824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentially active hypoglycemic agents from N1-nicotinoyl-2-pyrazolin-5-one derivatives and their N1-(oxynicotinoyl) analogues.
    Girges MM; Hanna MA; Rasala D; Berghot M
    Arzneimittelforschung; 1992 Nov; 42(11):1350-3. PubMed ID: 1492850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
    Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML
    J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycaemic activity of carbothioamides and related 1,2,4-thiodiazolidines.
    Chaubey M; Pandeya SN
    Farmaco; 1989 Oct; 44(10):987-95. PubMed ID: 2619864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, hypoglycemic activity and molecular modeling studies of pyrazole-3-carbohydrazides designed by a CoMFA model.
    Hernández-Vázquez E; Aguayo-Ortiz R; Ramírez-Espinosa JJ; Estrada-Soto S; Hernández-Luis F
    Eur J Med Chem; 2013 Nov; 69():10-21. PubMed ID: 23995214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.